Novavax experienced a significant surge on Thursday following a favorable settlement with the nongovernmental organization Gavi regarding its Covid-19 vaccine. Additionally, strong earnings reported by Moderna also contributed to the stock's rise.

Settlement with Gavi

In a recent news release, Novavax announced the settlement pertaining to a 2021 advance purchase agreement for its prototype Covid-19 vaccine. Gavi, an international organization focusing on improving vaccine access for children in lower-income countries, was involved in this agreement.

Novavax's Chief Executive, John Jacobs, expressed satisfaction with the agreement, emphasizing the collaborative effort towards achieving equitable access to safe and effective vaccines.

Agreement Details

After terminating the initial agreement in November 2022 due to Gavi not meeting the purchase requirements for Covid-19 vaccines, Novavax faced a $700 million refund claim from Gavi. As part of the settlement, Novavax made an initial payment of $75 million to Gavi and committed to annual deferred payments of $80 million until December 2028, totaling up to $400 million.

Stock Performance

Novavax's shares surged by 25% on Thursday, reaching $4.98, marking one of the most substantial percentage increases since July 10, 2023, according to Dow Jones Market Data. The positive momentum was further bolstered by Moderna's impressive fourth-quarter earnings, driving Moderna's stock up by 15% to $100.87.

Regulatory Approval and Company Outlook

Despite facing challenges over the past year, Novavax remains committed to its mission and continues to adapt to meet evolving demands in the healthcare industry.


European Central Bank Criticizes Bitcoin

Block Inc. Surprise Profit Quarter

Leave A Reply

Your email address will not be published. Required fields are marked *

Related posts

Richtech Robotics Shares Experience Significant Drop
News

Richtech Robotics Shares Experience Significant Drop

Richtech Robotics, a prominent robotics company, faces a significant drop in shares but hopes to rebound with AI advance...

Brown-Forman Corp. Reports Unexpected Decline in Q1 Profit
News

Brown-Forman Corp. Reports Unexpected Decline in Q1 Profit

Brown-Forman Corp. reports an unexpected decline in Q1 profit and slightly misses sales expectations, attributed to prio...

Stitch Fix Reports Narrowed Losses in Q4
News

Stitch Fix Reports Narrowed Losses in Q4

Stitch Fix reports a narrower loss in Q4, although revenue declined and the active customer base decreased. CEO remains...

Worldline Records Loss due to Impairment
News

Worldline Records Loss due to Impairment

Worldline reports a loss in 2023, impacting revenue and cash flow, leading to strategic changes and restructuring plans...